Financier | Commitments |
---|---|
IDA Credit | 5.00 |
P173787
Closed
Phoebe Folger
Kingdom of Bhutan
April 11, 2020
(as of board presentation)
April 17, 2020
April 27, 2020
US$ 5.00 million
Ministry of Health, Royal Government of Bhutan
2020
US$ 5.00 million
N/A
March 5, 2024
June 30, 2024
No
BANK APPROVED
Financier | Commitments |
---|---|
IDA Credit | 5.00 |
Product Line | IBRD/IDA |
---|---|
IBRD Commitment | N/A |
IDA Commitment | 5.00 |
IBRD + IDA Commitment | 5.00 |
Lending Instrument | |
---|---|
Grant Amount | N/A |
Total Project Cost** | 5.00 |
Period | Financier | Transaction Type | Amount (US$) |
---|---|---|---|
May 5, 2021 | IDA-66270 | Loan Disb | 29,358.12 |
Mar 15, 2021 | IDA-66270 | Int Charges | 69.82 |
Mar 15, 2021 | IDA-66270 | Int Charges | 69.82 |
Mar 15, 2021 | IDA-66270 | Int Charges | 10,400.98 |
Mar 15, 2021 | IDA-66270 | Int Charges | 10,400.98 |
Nov 23, 2020 | IDA-66270 | Loan Disb | 459,684.00 |
Oct 27, 2020 | IDA-66270 | Loan Disb | 743,715.56 |
Sep 15, 2020 | IDA-66270 | Int Charges | 3,666.43 |
Sep 15, 2020 | IDA-66270 | Int Charges | 3,666.43 |
May 29, 2020 | IDA-66270 | Loan Disb | 993,904.06 |
Jun 24, 2020 | IDA-66270 | Loan Disb | 850,268.80 |
Mar 21, 2022 | IDA-66270 | Loan Disb | 23,694.24 |
Sep 15, 2021 | IDA-66270 | Int Charges | 87.39 |
Sep 15, 2021 | IDA-66270 | Int Charges | 87.39 |
Sep 15, 2021 | IDA-66270 | Int Charges | 11,668.02 |
Sep 15, 2021 | IDA-66270 | Int Charges | 11,668.02 |
Aug 26, 2021 | IDA-66270 | Loan Disb | 45,377.28 |
Sep 15, 2022 | IDA-70980 | Int Charges | 8,347.72 |
Sep 15, 2022 | IDA-70980 | Int Charges | 8,347.72 |
Sep 1, 2022 | IDA-70980 | Loan Disb | 20,637.46 |
Mar 10, 2022 | IDA-66270 | Loan Disb | 2,000,000.00 |
Aug 23, 2022 | IDA-70980 | Loan Disb | 522,698.00 |
Jun 27, 2022 | IDA-70980 | Loan Disb | 440,000.00 |
Jun 21, 2022 | IDA-70980 | Loan Disb | 4,458,728.00 |
Mar 15, 2022 | IDA-66270 | Int Charges | 28.76 |
Mar 15, 2022 | IDA-66270 | Int Charges | 28.76 |
Mar 15, 2022 | IDA-66270 | Int Charges | 11,783.95 |
Mar 15, 2022 | IDA-66270 | Int Charges | 11,783.95 |
Mar 15, 2023 | IDA-70980 | Int Charges | 156.69 |
Mar 15, 2023 | IDA-70980 | Int Charges | 156.69 |
Mar 15, 2023 | IDA-66270 | Int Charges | 199.69 |
Mar 15, 2023 | IDA-66270 | Int Charges | 199.69 |
Mar 15, 2023 | IDA-66270 | Int Charges | 18,262.86 |
Mar 15, 2023 | IDA-66270 | Int Charges | 18,262.86 |
Mar 15, 2023 | IDA-70980 | Int Charges | 20,652.76 |
Mar 15, 2023 | IDA-70980 | Int Charges | 20,652.76 |
Sep 15, 2023 | IDA-66270 | Int Charges | 238.12 |
Sep 15, 2023 | IDA-66270 | Int Charges | 238.12 |
Sep 15, 2023 | IDA-66270 | Int Charges | 18,050.78 |
Sep 15, 2023 | IDA-66270 | Int Charges | 18,050.78 |
Jan 25, 2023 | IDA-70980 | Loan Disb | 926,726.80 |
Apr 28, 2023 | IDA-70980 | Loan Disb | 23,686.39 |
Sep 15, 2022 | IDA-66270 | Int Charges | 33.05 |
Sep 15, 2022 | IDA-66270 | Int Charges | 33.05 |
Sep 15, 2022 | IDA-66270 | Int Charges | 17,922.88 |
Sep 15, 2022 | IDA-66270 | Int Charges | 17,922.88 |
Jul 3, 2024 | IDA-70980 | Loan Disb | 53.87 |
Sep 15, 2023 | IDA-70980 | Int Charges | 680.68 |
Sep 15, 2023 | IDA-70980 | Int Charges | 680.68 |
Sep 15, 2023 | IDA-70980 | Int Charges | 23,657.65 |
Sep 15, 2023 | IDA-70980 | Int Charges | 23,657.65 |
Apr 18, 2022 | IDA-70980 | Loan Commitment | 10,000,000.00 |
Apr 17, 2020 | IDA-66270 | Loan Commitment | 5,000,000.00 |
May 9, 2024 | IDA-70980 | Loan Cancel | 3,032,550.00 |
Jul 3, 2024 | IDA-70980 | Loan Disb | 40,718.36 |
Mar 15, 2024 | IDA-70980 | Int Charges | 660.55 |
Mar 15, 2024 | IDA-70980 | Int Charges | 660.55 |
Mar 15, 2024 | IDA-70980 | Int Charges | 23,249.15 |
Mar 15, 2024 | IDA-70980 | Int Charges | 23,249.15 |
Mar 15, 2024 | IDA-66270 | Int Charges | 496.35 |
Mar 15, 2024 | IDA-66270 | Int Charges | 496.35 |
Mar 15, 2024 | IDA-66270 | Int Charges | 17,971.18 |
Mar 15, 2024 | IDA-66270 | Int Charges | 17,971.18 |
Name | Review | Date |
---|---|---|
Progress towards achievement of PDO | Satisfactory | 2025-03-17 |
Financial Management | Satisfactory | 2025-03-17 |
Procurement | Moderately Satisfactory | 2025-03-17 |
Project Management | Satisfactory | 2025-03-17 |
Monitoring and Evaluation | Satisfactory | 2025-03-17 |
Overall Implementation Progress (IP) | Satisfactory | 2025-03-17 |
INDICATOR | BASELINE | CURRENT | TARGET |
---|
Bhutan has activated its public health Emergency Operations Centre or a coordination mechanism for COVID-19 | Value | No | Yes | Yes |
Date | January 10, 2020 | June 1, 2023 | December 31, 2023 | |
Comment |
Percentage of suspected cases of COVID-19 cases reported and investigated based on national guidelines | Value | 0.00 | 100.00 | 90.00 |
Date | January 10, 2020 | June 1, 2023 | December 31, 2023 | |
Comment |
Number of acute healthcare facilities with isolation capacity | Value | 1.00 | 4.00 | 3.00 |
Date | January 10, 2020 | June 1, 2023 | December 31, 2023 | |
Comment |
Country adopted personal and community non-pharmaceutical interventions | Value | No | Yes | Yes |
Date | January 10, 2020 | June 1, 2023 | December 31, 2023 | |
Comment |
Percentage of population vaccinated, which is included in the priority population targets defined in national plan [by gender] | Value | 0.00 | 8.30 | 5.60 |
Date | September 29, 2021 | June 1, 2023 | December 31, 2023 | |
Comment |
Percentage of males vaccinated | Value | 0.00 | 48.60 | 50.00 |
Date | December 15, 2021 | June 1, 2023 | December 31, 2023 | |
Comment |
Percentage of females vaccinated | Value | 0.00 | 51.40 | 50.00 |
Date | December 15, 2021 | June 1, 2023 | December 31, 2023 | |
Comment |
Percentage of population boosted with a single vaccine dose, in line with WHO/SAGE guidance | Value | 0.00 | 45.80 | 28.00 |
Date | May 1, 2022 | June 1, 2023 | December 31, 2023 | |
Comment |
Percentage of males boosted with a single vaccine dose, in line with WHO/SAGE guidance | Value | 0.00 | 50.50 | 50.00 |
Date | May 1, 2022 | June 1, 2023 | December 31, 2023 | |
Comment |
Percentage of females boosted with a single vaccine dose, in line with WHO/SAGE guidance | Value | 0.00 | 49.50 | 50.00 |
Date | May 1, 2022 | June 1, 2023 | December 31, 2023 | |
Comment |
INDICATOR | BASELINE | CURRENT | TARGET |
---|
Number of health staff trained in infection prevention and control per MoH protocols | Value | 0.00 | 353.00 | 100.00 |
Date | January 10, 2020 | June 1, 2023 | December 31, 2023 | |
Comment |
Bhutan has contextualized its risk communication and community engagement strategies | Value | No | Yes | Yes |
Date | January 10, 2020 | June 1, 2023 | December 31, 2023 | |
Comment |
M&E system established to monitor COVID-19 preparedness and response plan | Value | No | Yes | Yes |
Date | January 10, 2020 | June 1, 2023 | December 31, 2023 | |
Comment |
Percentage of specimens submitted for SARS-COV2 laboratory testing and confirmed within WHO stipulated standard time | Value | 0.00 | 100.00 | 95.00 |
Date | January 10, 2020 | June 1, 2023 | December 31, 2023 | |
Comment |
Percentage of received grievances that are addressed (within specified time/protocol) | Value | 0.00 | 100.00 | 80.00 |
Date | January 10, 2020 | June 1, 2023 | December 31, 2023 | |
Comment |
Joint supervision and monitoring visits conducted | Value | 0.00 | 5.00 | 6.00 |
Date | January 10, 2020 | June 30, 2023 | December 31, 2023 | |
Comment |
Number of acute healthcare facilities with triage capacity | Value | 1.00 | 4.00 | 10.00 |
Date | January 10, 2020 | June 1, 2023 | December 31, 2023 | |
Comment |
A National Vaccination and Deployment Plan (NVDP) with input from relevant bodies (NITAG, DRA, National Immunization Program, National Regulatory Authority, AEFI committee), in line with WHO guidance | Value | No | Yes | Yes |
Date | December 31, 2020 | June 1, 2023 | December 31, 2023 | |
Comment |
Potential numbers of target populations estimated who will be prioritized for access to vaccines stratified by target group and geographic location | Value | No | Yes | Yes |
Date | December 31, 2020 | June 1, 2023 | December 31, 2023 | |
Comment |
Guidelines, documented procedures and tools for planning and conducting vaccine pharmacovigilance activities established | Value | No | Yes | Yes |
Date | December 31, 2020 | June 1, 2023 | December 31, 2023 | |
Comment |